Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The need for a dedicated surgical consent framework for robotic telesurgery: a global call to action.

Journal of robotic surgery·2026
Same author

Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients.

Translational behavioral medicine·2026
Same author

Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.

The Journal of international medical research·2026
Same author

Correction: Best practices in telesurgery: framework and recommendations from the society of robotic surgery (SRS) for safe and effective implementation.

Journal of robotic surgery·2025
Same author

Best practices in telesurgery: framework and recommendations from the society of robotic surgery (SRS) for safe and effective implementation.

Journal of robotic surgery·2025
Same author

Metformin and weight loss medication impact on survival outcomes in older women with obesity-related cancers.

Scientific reports·2025

Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

707

Integrating the Genomic Prostate Score into Clinical Practice Workflow.

David Albala1, Premal J Desai2, Vahan Kassabian3

  • 1Associated Medical Professionals of New York, Syracuse, New York.

Urology Practice
|August 18, 2023
PubMed
Summary

The Genomic Prostate Score (GPS) helps urologists decide between immediate intervention and active surveillance for prostate cancer patients. This guide standardizes GPS integration into clinical practice for better risk stratification.

Keywords:
biological assaygenomicsprostatic neoplasms

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.6K

Related Experiment Videos

Last Updated: Jul 19, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

707
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.6K

Area of Science:

  • Urology
  • Oncology
  • Genomics

Background:

  • Prostate cancer management involves deciding between intervention and active surveillance.
  • Gene expression profiling offers improved risk stratification for low-risk prostate cancer.
  • Genomic testing integration faces challenges in clinical standardization.

Purpose of the Study:

  • To standardize operational best practices for integrating the Genomic Prostate Score (GPS) into clinical practice.
  • To provide practical guidance for physicians on understanding, running, interpreting, and communicating GPS results.
  • To support informed clinical decision-making for prostate cancer patients.

Main Methods:

  • Development of best practices based on real-world evidence and expert experience.
  • Focus on the Oncotype DX® prostate cancer assay and its Genomic Prostate Score.
  • Guidance on integrating genomic testing into routine urological practice.

Main Results:

  • The Genomic Prostate Score (GPS) reflects tumor biology to guide initial treatment decisions.
  • Expert consensus provides a framework for clinical application of GPS.
  • Real-world evidence supports the utility of GPS in risk assessment.

Conclusions:

  • The article offers practical guidance for physicians using the Genomic Prostate Score (GPS).
  • GPS aids in informing decisions regarding active surveillance for prostate cancer.
  • Standardized use of GPS can improve patient management and outcomes.